CoChat

CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways

Open access

The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.

Abstract

CD47 is a receptor belonging to the immunoglobulin (Ig) superfamily and broadly expressed on cell membranes. Through interactions with ligands such as SIRPα, TSP-1, integrins, and SH2-domain bearing protein tyrosine phosphatase substrate-1 (SHPS-1), CD47 regulates numerous functions like cell adhesion, proliferation, apoptosis, migration, homeostasis, and the immune system. In this aspect, previous research has shown that CD47 modulates phagocytosis via macrophages, the transmigration of neutrophils, and the activation of T-cells, dendritic cells, and B-cells. Moreover, several studies have reported the increased expression of the CD47 receptor in a variety of diseases, including acute lymphoblastic leukemia (ALL), chronic myeloid leukemia, non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), bladder cancer, acute myeloid leukemia (AML), Gaucher disease, Multiple Sclerosis and stroke among others. The ubiquitous expression of the CD47 cell receptor on most resident cells of the CNS has previously been established through different methodologies. However, there is little information concerning its precise functions in the development of different neurodegenerative pathologies in the CNS. Consequently, further research pertaining to the specific functions and roles of CD47 and SIRP is required prior to its exploitation as a druggable approach for the targeting of various neurodegenerative diseases that affect the human population. The present review attempts to summarize the role of both CD47 and SIRP and their therapeutic potential in neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules26133943

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 NIREGs such as CD47 provide “don’t eat me signals” and keep microglia in a homeostatic state. Adapted from [14].
Figure 1 NIREGs such as CD47 provide “don’t eat me signals” and keep microglia in a homeostatic state. Adapted from [14].CC BY · PubMed Central
Figure 2 The cell-to-cell cross-talk via the SIRPα-CD47 signaling. (A) Bi-directional signaling between CD47 and SIRPα. CD47 and SIRPα are possibly co-expressed on a similar cell and their ligation could mediate the inter-cellular signaling in a bi-directional manner. Even though SIRPα-CD47 signaling in the microglia is incompletely understood, the specific contribution of SIRPα and CD47 has been examined. Moreover, CD47 and SIRPα interactions could be observed in the phagocytic function of the microglia. (B) SIRP signaling in microglia. SIRPα phosphorylation enables the docking and the recruitment of SHP-1 and SHP-2. In this regard, various studies have shown that SHP-1 and SHP-2 perform opposite biological functions. Different signaling pathways have been negatively regulated by SHP-1 for the inhibition of numerous cell functions like phagocytosis. On the contrary, events affecting the cellular activity such as migration, as well as growth, have been shown to be positively regulated by SHP-2 [5]. Abbreviation: GPCR: G protein-coupled receptor, SIRPα: Signal regulatory protein α, SHP 1/2: SH2 domain-containing phosphatases 1 and 2, SHIP: SH2 domain-containing inositol phosphatase.
Figure 2 The cell-to-cell cross-talk via the SIRPα-CD47 signaling. (A) Bi-directional signaling between CD47 and SIRPα. CD47 and SIRPα are possibly co-expressed on a similar cell and their ligation could mediate the inter-cellular signaling in a bi-directional manner. Even though SIRPα-CD47 signaling in the microglia is incompletely understood, the specific contribution of SIRPα and CD47 has been examined. Moreover, CD47 and SIRPα interactions could be observed in the phagocytic function of the microglia. (B) SIRP signaling in microglia. SIRPα phosphorylation enables the docking and the recruitment of SHP-1 and SHP-2. In this regard, various studies have shown that SHP-1 and SHP-2 perform opposite biological functions. Different signaling pathways have been negatively regulated by SHP-1 for the inhibition of numerous cell functions like phagocytosis. On the contrary, events affecting the cellular activity such as migration, as well as growth, have been shown to be positively regulated by SHP-2 [5]. Abbreviation: GPCR: G protein-coupled receptor, SIRPα: Signal regulatory protein α, SHP 1/2: SH2 domain-containing phosphatases 1 and 2, SHIP: SH2 domain-containing inositol phosphatase.CC BY · PubMed Central
Figure 3 Improvement of functional recovery from contusive thoracic SCI by CD47 inhibition. CD47 suppression increases the vascular patency following the SCI. Moreover, CD47 suppression reduces neutrophil extravasation into the contusion. For this reason, CD47 has been considered a new treatment target to treat SCI. Adapted from [7].
Figure 3 Improvement of functional recovery from contusive thoracic SCI by CD47 inhibition. CD47 suppression increases the vascular patency following the SCI. Moreover, CD47 suppression reduces neutrophil extravasation into the contusion. For this reason, CD47 has been considered a new treatment target to treat SCI. Adapted from [7].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 34

Metadata

Authors
Gheibihayat, S. M., Cabezas, R., Nikiforov, N. G., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A.
Affiliations
  • Department of Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd 8916188635, Iran
  • Universidad Antonio Nariño (CO)
  • Institute of Experimental Cardiology (RU)
  • Mashhad University of Medical Sciences (IR)
  • University of Missouri–Kansas City (US)
Corresponding author
Sahebkar, Amirhossein
Venue
Molecules
Publisher
MDPI AG
Published
2021-06-28
Volume
26
Issue
13
Pages
3943
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3174672518
Cited by
34
References
91
Citations by year
2026: 8 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 4
FWCI
0.46
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Russian Science Foundation (20-15-00337)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
CD47, SIRPα, neurodegeneration, neuroinflammation, central nervous system, phagocytosis, macrophages, thrombospondin-1, integrins, therapeutic targeting, multiple sclerosis, stroke
MeSH terms
Animals, Brain, Gaucher Disease, Humans, Inflammation, Multiple Sclerosis, Stroke, CD47 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.